Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.09 is 676% above its 5-year average of 1.04, around the middle of its 5-year range (0.00–14.17).
As of the fiscal period ended Tuesday, September 30, 2025. 85.35% above its 12-month average of 4.36.
Reported quarterly current ratio; no daily interpolation. Q2 FY2025 (2025-09-30): 8.09.
CURRENT RATIO
8.09
CURRENT RATIO AVG TTM
4.36
CURRENT RATIO AVG 3Y
1.48
CURRENT RATIO AVG 5Y
1.04
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+85.35%
CURRENT VS 3Y AVG
+445.27%
CURRENT VS 5Y AVG
+676.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 798 covered companies
CURRENT VS SECTOR MEDIAN
+125.04%
vs the sector median at left
Psyence Biomedical Ltd.
Market Cap
$95424.00
Current Ratio
8.09
TTM Avg
4.36
3Y Avg
1.48
5Y Avg
1.04
Market Cap
$109065.00
Current Ratio
0.94
TTM Avg
1.53
3Y Avg
2.70
5Y Avg
2.29
Market Cap
$30755.00
Current Ratio
4.22
TTM Avg
1.69
3Y Avg
2.61
5Y Avg
2.27
Market Cap
$381125.00
Current Ratio
0.78
TTM Avg
0.50
3Y Avg
0.69
5Y Avg
2.39
Market Cap
$484571.00
Current Ratio
3.59
TTM Avg
2.57
3Y Avg
4.32
5Y Avg
8.01
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Psyence Biomedical Ltd. (PBM) | $95424.00 | 8.09 | 4.36 | 1.48 | 1.04 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109065.00 | 0.94 | 1.53 | 2.70 | 2.29 |
| PRF Technologies Ltd. (PRFX)vs › | $72318.00 | 5.07 | 1.79 | 4.80 | 10.47 |
| Akanda Corp. (AKAN)vs › | $61495.00 | 0.22 | 0.98 | 0.64 | 0.52 |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30755.00 | 4.22 | 1.69 | 2.61 | 2.27 |
| NewGenIvf Group Limited (NIVF)vs › | $6039.00 | 3.12 | 2.15 | 1.85 | 1.56 |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | 2.41 | 3.89 | 3.24 | 3.47 |
| Niki BioSolutions, Inc. (NIKI)vs › | $381125.00 | 0.78 | 0.50 | 0.69 | 2.39 |
| XORTX Therapeutics Inc. (XRTX)vs › | $484571.00 | 3.59 | 2.57 | 4.32 | 8.01 |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | 0.06 | 0.15 | 3.14 | 7.02 |
Current Ratio
8.09
Quick Ratio
8.09
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-09-30 | 8.09 |
| 2024-09-30 | 0.64 |
| 2023-12-31 | 0.09 |
| 2023-09-30 | 0.01 |
| 2023-06-30 | 0.01 |
| 2023-03-31 | 0.02 |
| 2022-12-31 | 0.11 |
| 2022-09-30 | 2.89 |
| 2022-06-30 | 3.05 |
| 2022-03-31 | 5.59 |
| 2021-12-31 | 14.17 |
| 2021-09-30 | 0.04 |
| 2021-06-30 | 0.05 |
| 2021-03-31 | 0.00 |
